Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Gilbert

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
The American Journal of Medicine|February 1, 1987
Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibodyE M Gilbert, C W Dewitt, C C Eiswirth, et al.
Transplantation|April 1, 1989
A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3D G Renlund, J B O'Connell, E M Gilbert, et al.
The New England Journal of Medicine|July 15, 1993
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study GroupA M Feldman, M R Bristow, W W Parmley, et al.
Journal of the American College of Cardiology|October 1, 1986
Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two dosesJ L Anderson, J C Askins, E M Gilbert, et al.
Transplantation|July 1, 1990
A randomized trial of the immunosuppressive efficacy of vincristine in cardiac transplantationB G Crandall, E M Gilbert, D G Renlund, et al.
Transplantation Proceedings|December 27, 2012
Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathyN M Heikal, F M Bader, T B Martins, et al.
Circulation|December 1, 1996
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA InvestigatorsM R Bristow, E M Gilbert, W T Abraham, et al.
Journal of the American College of Cardiology|May 10, 2001
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study GroupM B Fowler, M Vera-Llonch, G Oster, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2011
Impact of donor left ventricular hypertrophy on survival after heart transplantO Wever Pinzon, G Stoddard, S G Drakos, et al.
Journal of Cardiac Failure|October 23, 1997
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study GroupJ N Cohn, M B Fowler, M R Bristow, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
The American Journal of Medicine|February 1, 1987
Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibodyE M Gilbert, C W Dewitt, C C Eiswirth, et al.
Transplantation|April 1, 1989
A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3D G Renlund, J B O'Connell, E M Gilbert, et al.
The New England Journal of Medicine|July 15, 1993
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study GroupA M Feldman, M R Bristow, W W Parmley, et al.
Journal of the American College of Cardiology|October 1, 1986
Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two dosesJ L Anderson, J C Askins, E M Gilbert, et al.
Transplantation|July 1, 1990
A randomized trial of the immunosuppressive efficacy of vincristine in cardiac transplantationB G Crandall, E M Gilbert, D G Renlund, et al.
Transplantation Proceedings|December 27, 2012
Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathyN M Heikal, F M Bader, T B Martins, et al.
Circulation|December 1, 1996
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA InvestigatorsM R Bristow, E M Gilbert, W T Abraham, et al.
Journal of the American College of Cardiology|May 10, 2001
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study GroupM B Fowler, M Vera-Llonch, G Oster, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2011
Impact of donor left ventricular hypertrophy on survival after heart transplantO Wever Pinzon, G Stoddard, S G Drakos, et al.
Journal of Cardiac Failure|October 23, 1997
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study GroupJ N Cohn, M B Fowler, M R Bristow, et al.
Pageof 9